CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −777 | $496.95 | $386K | 326,203 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −364 | $498.21 | $181K | 325,839 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −542 | $498.97 | $270K | 325,297 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −54 | $500.22 | $27K | 325,243 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $501.06 | $80K | 325,083 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $502.01 | $60K | 324,963 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $504.15 | $101K | 324,763 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $505.20 | $20K | 324,723 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $506.27 | $20K | 324,683 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $508.36 | $41K | 324,603 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $510.05 | $82K | 324,443 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 8,910 | ||
| 2026-09-01 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $135.42 | $1.3M | 333,943 |
| 2026-09-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $510.72 | $163K | 333,623 |
| 2026-09-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −825 | $511.95 | $422K | 332,798 |
| 2026-09-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,732 | $513.12 | $889K | 331,066 |
| 2026-09-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,454 | $514.09 | $1.8M | 327,612 |
| 2026-09-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,620 | $514.98 | $834K | 325,992 |
| 2026-09-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,469 | $516.03 | $758K | 324,523 |
| 2026-09-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $516.62 | $41K | 324,443 |
Page 43 of 121 · 2,404 trades